/Lists

Biotech Investors & VC Firms in North America

1590 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Foresite Capital
West HollywoodPre-Seed–Late Stage
61 people
ARCH Venture Partners
ChicagoSeed–Growth$50K – $250M
55 people
NFX
San FranciscoPre-Seed–Series B$250K – $5M
27 people
Frazier Healthcare Partners
SeattleGrowth$50M – $400M
95 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
77 people
Abstract Ventures
San FranciscoPre-Seed–Late Stage$250K – $750K
6 people
Deerfield Management Company
New YorkGrowth–Late Stage
90 people
Correlation Ventures
San FranciscoPre-Seed–Series A$100K – $4M
14 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people
Jumpstart Ventures
ClevelandPre-Seed–Series B$500K – $2M
66 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
33 people
Paladin Capital Group
WashingtonSeed–Late Stage$100K – $5M
73 people
Portfolia
San MateoSeed–Late Stage$10K
72 people
Sixth Street
San FranciscoPre-Seed–Late Stage$50M – $2.5B
81 people
IDEA NC
DurhamPre-Seed–Late Stage$250K – $2M
3 people
Expert DOJO
Santa MonicaPre-Seed–Series A$50K – $100K
14 people
Amplify Partners
Menlo ParkPre-Seed–Series A$500K – $5M
30 people
Pillar VC
BostonPre-Seed–Series B$50K – $4M
68 people
Bantam Group
WestwoodPre-Seed–Series A
1 person
WCAS
New YorkGrowth–Late Stage
91 people
Golden Seeds
FlushingPre-Seed–Series A$250K – $2M
62 people
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
23 people
AlleyCorp
New YorkPre-Seed–Series A$1M – $5M
32 people
TPG
San FranciscoGrowth–Late Stage
75 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.